Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin
Authors:
- Xiaokui HuoXHXiaokui Huo
- Qi LiuQLQi Liu
- Changyuan WangCWChangyuan Wang
- Qiang MengQMQiang Meng
- Huijun SunHSHuijun Sun
- Jinyong PengJPJinyong Peng
- Xiaochi MaXMXiaochi Ma
- Kexin LiuKLKexin Liu
- 1 November 2013
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 50 (3-4) , 420-428
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Drug Transporters in Drug Efficacy and ToxicityAnnual Review of Pharmacology and Toxicology, 2012
- The Utility of In Vitro Data in Making Accurate Predictions of Human P-Glycoprotein-Mediated Drug-Drug Interactions: A Case Study for AZD5672Drug Metabolism and Disposition, 2011
- Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transportersXenobiotica, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Mechanisms of the Regulation of the IntestinalExchanger NHE3Journal of Biomedicine and Biotechnology, 2009
- Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in ratsEuropean Journal of Pharmaceutical Sciences, 2009
- Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and LabelingClinical Pharmacology & Therapeutics, 2007
- Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactionsCancer Letters, 2002
- Transport of bestatin in rat renal brush-border membrane vesiclesBiochemical Pharmacology, 1993
- Induction of Multidrug Resistance in Human Cells by Transient Exposure to Different Chemotherapeutic DrugsJNCI: Journal of the National Cancer Institute, 1993